In a trial, sotagliflozin use in patients with diabetes and chronic kidney disease (CKD) was associated with lower risk of ischemic cardiovascular outcomes.
From 1990 to 2023, there was a decrease in the number of births and, in general, total fertility rates (GFRs and TFRs), ...
From 1990 to 2023, there was a decrease in the number of births, general fertility rates, and total fertility rates in the United States.
Researchers have found in a new study that patients receiving a combination of metformin and SGLT2 inhibitors experienced a ...
Cognitively impaired patients with CKD more frequently experience a host of health problems and are at higher risk for death. Cognitive impairment in patients with chronic kidney disease (CKD) is ...
France: A recent case published in BMC Nephrology highlights the possible role of tranexamic acid (TXA) in precipitating ...
Presented positive updated data from ASPEN-06 Phase 2 trial demonstrating evorpacept generates strong response and durable clinical benefit in ...
Adding cabozantinib to first-line treatment with nivolumab and ipilimumab improved PFS — but not OS — in patients with RCC.
Vertex Pharmaceuticals Incorporated ( NASDAQ: VRTX) TD Cowen 45th Annual Health Care Conference Transcript March 3, 2025 3:10 PM ET David Altshuler - Executive Vice President, Global Research and CSO ...
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results